Paper16623765
A library of gene expression signatures to illuminate normal and pathological lymphoid biology.
Shaffer AL and 8 others. Immunol Rev, 2006. Cited by 180 papers, by iCite.
Cite this record
ConductScience Library. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Papers, record 16623765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16623765
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Gene Expression Regulation, Leukemic | Major topic |
| Gene Library | Major topic |
| Genomics | Major topic |
| Leukemia, B-Cell | Major topic |
| Gene Expression | |
| Humans | |
| Transcription Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| Z01CT000260 | NIH | NIH RePORTER | |||
| Z01SC004024 | NIH | NIH RePORTER | |||
| ZIACT000260 | NIH | NIH RePORTER |
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42595846 | A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2. | Leukemia | 2026 | https://conductscience.org/library/papers/42595846 | PubMed |
| 42571242 | Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42571242 | PubMed |
| 41591906 | RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41591906 | PubMed |
| 40510016 | Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma. | Am J Hematol | 2025 | https://conductscience.org/library/papers/40510016 | PubMed |
| 40040873 | Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma. | J Natl Cancer Cent | 2025 | https://conductscience.org/library/papers/40040873 | PubMed |
| 39869833 | Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response. | Blood | 2025 | https://conductscience.org/library/papers/39869833 | PubMed |
| 39684518 | Development and Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684518 | PubMed |
| 39305307 | Distinct pathway activities are associated with prognosis and response to bortezomib-containing treatment in MCL1-M based molecular subtypes of multiple myeloma. | Ann Hematol | 2024 | https://conductscience.org/library/papers/39305307 | PubMed |
| 38701792 | Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38701792 | PubMed |
| 38570506 | Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. | Nat Commun | 2024 | https://conductscience.org/library/papers/38570506 | PubMed |
| 38428430 | Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38428430 | PubMed |
| 38215749 | Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38215749 | PubMed |
| 37600821 | Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma. | Front Immunol | 2023 | https://conductscience.org/library/papers/37600821 | PubMed |
| 37141112 | Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. | Cancer Discov | 2023 | https://conductscience.org/library/papers/37141112 | PubMed |
| 36818048 | Molecular classification and therapeutics in diffuse large B-cell lymphoma. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/36818048 | PubMed |
| 36656933 | BTG1 mutation yields supercompetitive B cells primed for malignant transformation. | Science | 2023 | https://conductscience.org/library/papers/36656933 | PubMed |
| 36503430 | Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. | Mol Cancer | 2022 | https://conductscience.org/library/papers/36503430 | PubMed |
| 36181613 | Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A. | Discov Oncol | 2022 | https://conductscience.org/library/papers/36181613 | PubMed |
| 36046113 | The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type. | Explor Target Antitumor Ther | 2021 | https://conductscience.org/library/papers/36046113 | PubMed |
| 34778802 | Overcoming Acquired Epigenetic Resistance to BTK Inhibitors. | Blood Cancer Discov | 2021 | https://conductscience.org/library/papers/34778802 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL6 | 604 | PubTator's text mining | https://conductscience.org/library/genes/604 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PRDM1 | 639 | PubTator's text mining | https://conductscience.org/library/genes/639 | NCBI Gene |
| XBP1 | 7494 | PubTator's text mining | https://conductscience.org/library/genes/7494 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16623765
GET https://conductscience.org/api/papers/v1/16623765/cited_by?page=2